Biochemistry
4 questionsLocation of gene on chromosome is identified by
Tyrosine kinase receptor is associated with proto-oncogene -
Which of the following is not a part of extracellular matrix (ECM)?
What is the classification of Carcinoembryonic Antigen (CEA)?
NEET-PG 2015 - Biochemistry NEET-PG Practice Questions and MCQs
Question 341: Location of gene on chromosome is identified by
- A. Karyotyping
- B. Genetic mapping (Correct Answer)
- C. Microarray
- D. Genomic imprinting
Explanation: ***Genetic mapping*** - **Genetic mapping** (also called chromosome mapping) uses various techniques to determine the **physical location (locus)** of genes on a chromosome. - Techniques include **linkage analysis**, **FISH (Fluorescence In Situ Hybridization)**, chromosomal banding, and analysis of **inheritance patterns** of traits and genetic markers. - This identifies both the **relative positions** between genes and their **absolute chromosomal addresses**. *Karyotyping* - **Karyotyping** is a technique that visualizes the entire set of chromosomes in an organism. - While it can identify **large chromosomal abnormalities** like aneuploidy or major deletions/insertions, it does not pinpoint the exact location of a specific gene. *Microarray* - **Microarray** technology is used to study the expression levels of thousands of genes simultaneously or to detect specific genetic variations. - It does not directly map the physical location of a gene on a chromosome. *Genomic imprinting* - **Genomic imprinting** is an epigenetic phenomenon where certain genes are expressed in a **parent-of-origin-specific manner**. - It describes a mechanism of gene regulation rather than a method for identifying the location of a gene on a chromosome.
Question 342: Tyrosine kinase receptor is associated with proto-oncogene -
- A. RAS (RAt Sarcoma)
- B. RET (REarranged during Transfection) (Correct Answer)
- C. RB (Retinoblastoma gene)
- D. MYC (Myelocytomatosis oncogene)
Explanation: ***RET*** - RET is a **tyrosine kinase receptor** that plays a crucial role in cell signaling and development [1][2]. - It is associated with several **neoplasms**, including medullary thyroid carcinoma and multiple endocrine neoplasia type 2 [1]. *RB* - RB (Retinoblastoma protein) is a **tumor suppressor gene**, not a proto-oncogene or receptor. - Its role is largely in regulating the **cell cycle**, particularly in preventing excessive cell growth. *RAS* - RAS is a family of **GTPase proteins** involved in transmitting signals within cells, but it is not a receptor itself [1]. - It is classified as an **oncogene**, but does not function as a tyrosine kinase receptor [2]. *MYC* - MYC is a **transcription factor** involved in cell cycle progression and growth, not a tyrosine kinase receptor [2]. - It is considered an **oncogene** that promotes cellular proliferation, but it doesn't have tyrosine kinase activity [3][4]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1097-1098. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 291-292. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. With Illustrations By, pp. 28-29. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 293-294.
Question 343: Which of the following is not a part of extracellular matrix (ECM)?
- A. Lectins (Correct Answer)
- B. Fibronectin
- C. Laminin
- D. Proteoglycans
Explanation: ***Lectins*** - **Lectins** are carbohydrate-binding proteins involved in various cellular processes but are typically found **on cell surfaces** or within cells, not as a major structural component of the ECM. - While they can interact with ECM components, they are not considered a direct structural element of the extracellular matrix itself. *Fibronectin* - **Fibronectin** is a critical **glycoprotein** in the ECM, playing a vital role in cell adhesion, growth, migration, and differentiation. - It links cells to collagen fibers and other ECM components, forming an essential scaffold. *Laminin* - **Laminin** is a major **glycoprotein** component of the **basal lamina**, a specialized layer of the ECM found beneath epithelial cells. - It helps in cell attachment, differentiation, and migration. *Proteoglycans* - **Proteoglycans** are macromolecules consisting of a **core protein** covalently linked to one or more **glycosaminoglycan (GAG) chains**. - They are abundant in the ECM, where they contribute to its structural integrity, hydration, and can regulate the diffusion of molecules.
Question 344: What is the classification of Carcinoembryonic Antigen (CEA)?
- A. Glycoprotein (Correct Answer)
- B. Lipoprotein
- C. Phosphoprotein
- D. Nucleoprotein
Explanation: ***Glycoprotein*** - Carcinoembryonic Antigen (CEA) is classified as a **glycoprotein** due to its structure, which consists of both **carbohydrate** and **protein** components. - This glycosylation is crucial for its function as a cell adhesion molecule and its recognition in diagnostic assays. *Lipoprotein* - **Lipoproteins** are complexes of lipids and proteins that function primarily in **lipid transport** in the blood. - CEA's primary role and structure are not related to lipid transport or being predominantly lipid-based. *Phosphoprotein* - A **phosphoprotein** is a protein that has been **covalently modified by the addition of a phosphate group**, a process crucial for cell signaling. - While proteins can be phosphorylated, the defining characteristic and major classification of CEA is its extensive glycosylation rather than phosphorylation state. *Nucleoprotein* - **Nucleoproteins** are proteins that are **structurally associated with nucleic acids** (DNA or RNA), such as histones or ribosomal proteins. - CEA does not have a structural or functional association with nucleic acids.
Internal Medicine
1 questionsWhat is the mode of inheritance for the most common form of hypophosphatemic rickets?
NEET-PG 2015 - Internal Medicine NEET-PG Practice Questions and MCQs
Question 341: What is the mode of inheritance for the most common form of hypophosphatemic rickets?
- A. Autosomal Recessive (AR)
- B. Autosomal Dominant (AD)
- C. X-Linked Recessive (XR)
- D. X-Linked Dominant (XD) (Correct Answer)
Explanation: ***X-Linked Dominant (XD)*** - The most common form of hypophosphatemic rickets is **X-linked hypophosphatemic rickets (XLH)**, which is inherited in an X-linked dominant pattern. - This condition is caused by mutations in the **PHEX gene** on the X chromosome, leading to impaired phosphate reabsorption in the kidneys. *Autosomal Recessive (AR)* - While some rare forms of hypophosphatemic rickets exist with **autosomal recessive** inheritance, they are not the most common. - These forms typically involve mutations in genes affecting phosphate transport or vitamin D metabolism, distinct from the primary defect in XLH. *Autosomal Dominant (AD)* - There are also rare **autosomal dominant** forms of hypophosphatemic rickets, such as hereditary hypophosphatemic rickets with hypercalciuria (HHRH) or autosomal dominant hypophosphatemic rickets (ADHR). - However, these are less common than the X-linked dominant form (XLH). *X-Linked Recessive (XR)* - **X-linked recessive** inheritance typically affects males more severely and exclusively, with carrier females usually unaffected or mildly affected. - In X-linked dominant conditions like XLH, both males and females are affected, though females may exhibit variable expressivity.
Pathology
4 questionsWhich of the following is a chromosomal instability syndrome?
Structure of chromosomes is studied by?
Reversible change from one cell type to another is known as -
Which of the following is an oncogene?
NEET-PG 2015 - Pathology NEET-PG Practice Questions and MCQs
Question 341: Which of the following is a chromosomal instability syndrome?
- A. Bloom syndrome (Correct Answer)
- B. Fanconi anemia
- C. Ataxia-telangiectasia
- D. None of the options
Explanation: ***Bloom syndrome*** - Bloom syndrome is the **classic chromosomal instability syndrome** characterized by **spontaneous chromosomal breaks, gaps, and markedly increased sister chromatid exchanges (SCEs)**. - It is an **autosomal recessive disorder** caused by mutations in the BLM gene (RecQ helicase family), leading to impaired DNA repair and replication [1]. - Patients exhibit **growth deficiency, photosensitive facial erythema, immunodeficiency**, and a dramatically **increased risk of cancers** at an early age. - The **hallmark laboratory finding** is a 10-fold increase in sister chromatid exchanges, making it the **prototypical chromosomal instability disorder**. *Fanconi anemia* - Fanconi anemia is **also a chromosomal instability syndrome**, characterized by **chromosomal breakage** when lymphocytes are exposed to DNA crosslinking agents (DEB/MMC test) [1]. - However, it presents primarily with **progressive bone marrow failure, congenital anomalies** (thumb/radial ray, café-au-lait spots, short stature), and increased cancer risk (particularly AML and squamous cell carcinomas). - While chromosomal instability is present, the **clinical presentation is dominated by bone marrow failure**, distinguishing it from Bloom syndrome. *Ataxia-telangiectasia* - Ataxia-telangiectasia is **also a chromosomal instability syndrome** with chromosomal breaks and translocations (especially involving chromosomes 7 and 14) [1]. - Caused by **ATM gene mutations**, leading to defective DNA double-strand break repair and cell cycle checkpoint control. - However, it is **clinically characterized primarily by progressive cerebellar ataxia, oculocutaneous telangiectasias, immunodeficiency**, and elevated AFP levels. - The **neurological manifestations predominate** the clinical picture, distinguishing it from Bloom syndrome. *None of the options* - This option is incorrect because Bloom syndrome is the **classic and prototypical chromosomal instability syndrome**, characterized predominantly by chromosomal instability features rather than other system involvement. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 322-323.
Question 342: Structure of chromosomes is studied by?
- A. C-banding
- B. Q-banding
- C. BrdU staining
- D. G-banding (Correct Answer)
Explanation: ***G-banding*** - G-banding is the most commonly used method for the **detailed examination of chromosomes**, allowing visualization of banding patterns [1][2]. - It facilitates the identification of **chromosomal abnormalities** and is essential in **cytogenetic studies** [1][2]. *Q-banding* - Q-banding reveals a different pattern that is primarily used for **detection of specific chromosome markers** but is less common than G-banding. - It is more useful for cases requiring **fluorescent bright bands** but not for overall structural analysis. *C-banding* - C-banding specifically highlights the **centromeric regions** of chromosomes, not the overall structure. - It is limited in scope compared to G-banding since it doesn't provide a complete picture of chromosome morphology. *Brd V-staining* - Brd V-staining focuses on specific **DNA regions** and is related to the **visualization of viral DNA** in infected cells rather than chromosome structure. - It does not offer insights into the **general structural characteristics** of chromosomes like G-banding does. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 54-55. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 167-168.
Question 343: Reversible change from one cell type to another is known as -
- A. Hypertrophy
- B. Dysplasia
- C. Hyperplasia
- D. Metaplasia (Correct Answer)
Explanation: ***Metaplesia*** - Refers to the **reversible change** from one cell type to another in response to chronic irritation or damage [1][2]. - It often occurs as an adaptive response in **epithelial tissues**, such as in the respiratory tract in smokers [1][2]. *Hypertrophy* - Represents an **increase in cell size** rather than a change in cell type [2]. - It is often a response to increased functional demand, as seen in **cardiac muscle** in athletes. *Hyperplesia* - Refers to an **increase in cell number** within a tissue or organ, not a change in cell type [2]. - Common in conditions such as **benign prostatic hyperplasia** but does not involve differentiation into other cell types. *Dysplasia* - Indicates an **abnormal growth or development** of cells, leading to disordered morphology rather than a transformation into another cell type. - It is often a precursor to cancer but does not signify the reversible nature of metaplasia. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 49. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 85-92.
Question 344: Which of the following is an oncogene?
- A. WT-1
- B. Rb
- C. p53
- D. RAS (Correct Answer)
Explanation: ***RAS*** - RAS is an **oncogene**, not a tumor suppressor gene; it promotes cell proliferation and survival [1]. - Mutations in RAS lead to uncontrolled cell division, contributing to various cancers. *p53* - p53 is a crucial **tumor suppressor gene** responsible for regulating the cell cycle and preventing tumor formation [1,2]. - It functions by inducing apoptosis in cells with damaged DNA, preventing their proliferation [2]. *WT-1* - WT-1 is a **tumor suppressor gene** associated with Wilms' tumor and regulates kidney and gonadal development. - It plays a role in cell growth and differentiation, preventing tumorigenesis when functioning correctly. *Rb* - The Rb gene encodes the **retinoblastoma protein**, a key tumor suppressor that regulates the cell cycle by inhibiting cell division [1,2]. - Loss of Rb function is primarily associated with retinoblastoma and other cancers, indicating its critical role in tumor suppression [1,2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 297-301. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 227-228.
Psychiatry
1 questionsAll of the following are true about Down syndrome except for one.
NEET-PG 2015 - Psychiatry NEET-PG Practice Questions and MCQs
Question 341: All of the following are true about Down syndrome except for one.
- A. Incidence of Robertsonian translocation is 1:1000 (Correct Answer)
- B. Most common cause is trisomy 21
- C. Mosaicism 21 has no association with maternal age
- D. Extra chromosome is of maternal origin
- E. Incidence increases with advanced maternal age
Explanation: **Incidence of Robertsonian translocation is 1:1000** - This statement is **not accurate** for Down syndrome. Robertsonian translocation accounts for only about **3-4% of Down syndrome cases**, not a general population incidence of 1:1000. - The vast majority of Down syndrome cases (~95%) are due to trisomy 21 from nondisjunction, not translocation. - This is the **correct answer** as it is the FALSE statement. *Extra chromosome is of maternal origin* - In approximately **90-95% of Down syndrome cases**, the extra copy of chromosome 21 originates from the mother due to **nondisjunction** during meiosis. - This maternal origin is strongly correlated with **advanced maternal age**. *Most common cause is trisomy 21* - **Trisomy 21** (due to meiotic nondisjunction) accounts for about **95% of all Down syndrome cases**, making it the most common genetic mechanism. - This results in three separate copies of chromosome 21 in all body cells. *Mosaicism 21 has no association with maternal age* - **Mosaic Down syndrome** occurs when nondisjunction happens *after fertilization* in early embryonic development, leading to a mixture of cells with normal and trisomic cells. - Because it is a **post-zygotic event**, its incidence is independent of **maternal age**, unlike full trisomy 21. *Incidence increases with advanced maternal age* - **TRUE statement** - The risk of Down syndrome (particularly trisomy 21) increases significantly with **maternal age**. - Risk is approximately 1:1500 at age 20, 1:1000 at age 30, 1:400 at age 35, and 1:100 at age 40. - This is due to increased risk of meiotic nondisjunction in older oocytes.